ConductScience.org, home

Comparison · NCT01823328-58ec173b

Ketamine vs Etomidate: Number of Patients With First-pass Success

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Ketamine vs Etomidate: Number of Patients With First-pass Success. Trial comparisons, record NCT01823328-58ec173b. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01823328-58ec173b

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.9520.8670.983wilson
Risk in group 20.8960.80.948wilson
Risk difference, group 1 minus group 20.0561-0.04360.157newcombe hybrid score
Risk ratio, group 1 over group 21.060.9621.17log
Odds ratio, group 1 over group 22.290.5669.3log
Number needed to treat, for one more participant with the outcome on Ketamine than on Etomidate17.8from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1KetamineSubjects in the ketamine arm will receive ketamine for sedation prior to rapid sequence intubation (RSI).~Ketamine: Subjects will receive ketamine for sedation prior to rapid sequence intubation.5962OG000
Group 2EtomidateSubjects in the etomidate arm will receive etomidate for sedation prior to rapid sequence intubation (RSI).~Etomidate: Subjects will receive etomidate for sedation prior to rapid sequence intubation.6067OG001

Outcome

Type
SECONDARY
Title
Number of Patients With First-pass Success
Description
The rate of first pass success, defined as successful tracheal intubation on the first attempt. An attempt is defined as the insertion and subsequent removal of the laryngoscopic device from the patient's mouth, regardless of whether an endotracheal tube was inserted.
Time frame
up to 5 minutes (average time frame)
Population

Source ClinicalTrials.gov

Trial

Title
Ketamine Versus Etomidate for Rapid Sequence Intubation
NCT number
NCT01823328
Phases
PHASE4
Conditions
Airway Control, Anesthesia, Intubation, Complication
Interventions
Ketamine, Etomidate
Lead sponsor
Hennepin Healthcare Research Institute
Results first posted
2019-05-24

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01823328-58ec173b